Abstract
Hepatitis C virus (HCV) infection is closely tied to the lipid metabolism of liver cells. Here we identify the triglyceride-synthesizing enzyme diacylglycerol acyltransferase-1 (DGAT1) as a key host factor for HCV infection. DGAT1 interacts with the viral nucleocapsid core and is required for the trafficking of core to lipid droplets. Inhibition of DGAT1 activity or RNAi-mediated knockdown of DGAT1 severely impairs infectious virion production, implicating DGAT1 as a new target for antiviral therapy.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Moradpour, D., Penin, F. & Rice, C.M. Nat. Rev. Microbiol. 5, 453–463 (2007).
Miyanari, Y. et al. Nat. Cell Biol. 9, 1089–1097 (2007).
Roingeard, P., Hourioux, C., Blanchard, E. & Prensier, G. Histochem. Cell Biol. 130, 561–566 (2008).
Boulant, S., Targett-Adams, P. & McLauchlan, J. J. Gen. Virol. 88, 2204–2213 (2007).
Huang, H. et al. Proc. Natl. Acad. Sci. USA 104, 5848–5853 (2007).
Chang, K.S., Jiang, J., Cai, Z. & Luo, G. J. Virol. 81, 13783–13793 (2007).
Gastaminza, P. et al. J. Virol. 82, 2120–2129 (2008).
Farese, R.V. Jr. & Walther, T.C. Cell 139, 855–860 (2009).
Yen, C.L., Stone, S.J., Koliwad, S., Harris, C. & Farese, R.V. Jr. J. Lipid Res. 49, 2283–2301 (2008).
Smith, S.J. et al. Nat. Genet. 25, 87–90 (2000).
Stone, S.J. et al. J. Biol. Chem. 279, 11767–11776 (2004).
Wakita, T. et al. Nat. Med. 11, 791–796 (2005).
Lindenbach, B.D. et al. Science 309, 623–626 (2005).
Zhong, J. et al. Proc. Natl. Acad. Sci. USA 102, 9294–9299 (2005).
Podevin, P. et al. Gastroenterology 10.1053/j.gastro.2010.06.058 (2010).
Barba, G. et al. Proc. Natl. Acad. Sci. USA 94, 1200–1205 (1997).
Selby, M.J. et al. J. Gen. Virol. 74, 1103–1113 (1993).
McLauchlan, J., Lemberg, M.K., Hope, G. & Martoglio, B. EMBO J. 21, 3980–3988 (2002).
Ma, Y., Yates, J., Liang, Y., Lemon, S.M. & Yi, M. J. Virol. 82, 7624–7639 (2008).
Targett-Adams, P., Boulant, S. & McLauchlan, J. J. Virol. 82, 2182–2195 (2008).
Acknowledgements
We thank E. Yen (University of North Carolina–Chapel Hill) for Sf9 cell lysates, R. Bartenschlager (University of Heidelberg) for Luc-Jc1, Luc-JFH1, Jc1 constructs and Huh7 Lunet cells, C.M. Rice (Rockefeller University) for Huh7.5 cells, F.V. Chisari (Scripps Research Institute) for Huh7.5.1 cells, J. McLauchlan (Medical Research Council Virology Unit) for JFH1, JFH1 GND and JFH1ΔE1E2, T. Wakita (National Institute of Infectious Diseases, Japan) for the JFH1 construct and M. Spindler (Gladstone Institute of Cardiovascular Disease) for the pSicoRMS. We thank the members of the Ott and Farese laboratories for support. This work was supported by funds from the Gladstone Institutes, the Hellman Family Foundation (M.O.) and the US National Institutes of Health (R03 AI069090 (M.O.); R01 DK056084 (R.V.F. Jr.); P30 DK026743 (University of California–San Francisco Liver Center)). We gratefully acknowledge support through fellowships from the Human Frontiers Science Program (E.H.), the Agence nationale de recherches sur le sida et les hépatites virales (C. Hernandez and A.C.), and a training grant from the US National Institute of Diabetes and Digestive and Kidney Diseases (C. Harris).
Author information
Authors and Affiliations
Contributions
E.H. designed, performed and analyzed most of the experiments and wrote the manuscript. C. Harris and R.V.F. Jr. provided the DGAT1 inhibitor. C. Harris also performed DGAT activity assays, analyzed data and edited the manuscript. C. Hernandez and A.C. performed the experiments in human primary hepatocytes. K.K. constructed the DGAT1 mutants and performed some of the immunoprecipitation experiments. A.R.R., R.V.F. Jr. and M.O. supervised this work, analyzed data and edited (A.R.R. and R.V.F.) or wrote (M.O.) the manuscript.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Supplementary information
Supplementary Text and Figures
Supplementary Figures 1–7 and Supplementary Methods (PDF 1396 kb)
Rights and permissions
About this article
Cite this article
Herker, E., Harris, C., Hernandez, C. et al. Efficient hepatitis C virus particle formation requires diacylglycerol acyltransferase-1. Nat Med 16, 1295–1298 (2010). https://doi.org/10.1038/nm.2238
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/nm.2238
This article is cited by
-
Emerging role of lipophagy in liver disorders
Molecular and Cellular Biochemistry (2023)
-
The envelope protein of Zika virus interacts with apolipoprotein E early in the infectious cycle and this interaction is conserved on the secreted viral particles
Virology Journal (2022)
-
A review on hepatitis C virus: role of viral and host-cellular factors in replication and existing therapeutic strategies
Egyptian Liver Journal (2022)
-
Viral hijacking of cellular metabolism
BMC Biology (2019)
-
Plant-derived antivirals against hepatitis c virus infection
Virology Journal (2018)